lobbying_activities: 1228251
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1228251 | 8bc1055f-a5e0-4993-b03d-2c6e42f429a3 | Q1 | MCKENNA, LONG & ALDRIDGE | 76913 | REVANCE THERAPEUTICS, INC. | 2012 | first_quarter | PHA | Any issues impacting biopharmaceutical companies | 0 | 0 | 2012-04-16T15:21:42.243000-04:00 |